NanoViricides Statistics

Total Valuation

NanoViricides has a market cap or net worth of $18.93 million. The enterprise value is $14.97 million.

Market Cap	18.93M
Enterprise Value	14.97M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, before market open.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

NanoViricides has 15.64 million shares outstanding. The number of shares has increased by 11.80% in one year.

Current Share Class	15.64M
Shares Outstanding	15.64M
Shares Change (YoY)	+11.80%
Shares Change (QoQ)	+6.24%
Owned by Insiders (%)	0.61%
Owned by Institutions (%)	9.32%
Float	15.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.82
P/TBV Ratio	1.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.44

Current Ratio	3.44
Quick Ratio	3.34
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-63,937.24

Financial Efficiency

Return on equity (ROE) is -82.01% and return on invested capital (ROIC) is -52.14%.

Return on Equity (ROE)	-82.01%
Return on Assets (ROA)	-47.69%
Return on Invested Capital (ROIC)	-52.14%
Return on Capital Employed (ROCE)	-91.72%
Revenue Per Employee	n/a
Profits Per Employee	-$1.34M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.08% in the last 52 weeks. The beta is 1.14, so NanoViricides's price volatility has been higher than the market average.

Beta (5Y)	1.14
52-Week Price Change	+7.08%
50-Day Moving Average	1.25
200-Day Moving Average	1.56
Relative Strength Index (RSI)	44.97
Average Volume (20 Days)	164,912

Short Selling Information

The latest short interest is 295,097, so 1.89% of the outstanding shares have been sold short.

Short Interest	295,097
Short Previous Month	448,955
Short % of Shares Out	1.89%
Short % of Float	1.96%
Short Ratio (days to cover)	1.64

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.53M
Pretax Income	n/a
Net Income	-9.36M
EBITDA	-8.75M
EBIT	-9.53M
Earnings Per Share (EPS)	-$0.72

Full Income Statement

Balance Sheet

The company has $3.96 million in cash and n/a in debt, giving a net cash position of $3.96 million or $0.25 per share.

Cash & Cash Equivalents	3.96M
Total Debt	n/a
Net Cash	3.96M
Net Cash Per Share	$0.25
Equity (Book Value)	10.39M
Book Value Per Share	0.66
Working Capital	2.89M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.21 million and capital expenditures -$189,559, giving a free cash flow of -$8.40 million.

Operating Cash Flow	-8.21M
Capital Expenditures	-189,559
Free Cash Flow	-8.40M
FCF Per Share	-$0.54

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NanoViricides does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.80%
Shareholder Yield	n/a
Earnings Yield	-49.48%
FCF Yield	-44.38%

Analyst Forecast

The average price target for NanoViricides is $6.50, which is 437.19% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.50
Price Target Difference	437.19%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on September 24, 2019. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Sep 24, 2019
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1